Introduction
Influenza virus causes worldwide seasonal epidemics and, occasionally, pandemics. The severity of disease ranges from asymptomatic to very severe fulminating illness with pneumonia and acute respiratory distress syndrome (ARDS), and with an increased risk of bacterial superinfection and pneumonia further complicating the disease course [1, 2] . Although most cases of influenza virus infection are self-limiting, an estimated 0Á04-0Á4% of infected individuals become severely ill during seasonal epidemics, with significant increases during pandemics [2] . Several predisposing factors are known to increase the risk of severe influenza. These include old age, pregnancy, smoking, chronic diseases, such as pulmonary or cardiovascular disease and diabetes, as well as compromised immune responses due to malignancy, therapeutics or HIV infection [1] . Influenza viruses have single-stranded negative-sense RNA genomes, and most cases of human influenza are caused by influenza A (IAV) and B viruses. The swine flu pandemic in 2009-10 was an IAV H1N1 strain evolved by reassortment in swine [3] .
The first line of defence against influenza virus is represented by the innate immune system, in which the induction of interferons (IFN) plays a major role [4, 5] . The pattern recognition receptor Toll-like receptor (TLR)7, which recognizes single-stranded RNA (ssRNA), is essential for induction of type I IFN, especially IFN-a, in plasmacytoid dendritic cells (pDCs). This is mediated through activation of the adaptor myeloid differentiation primary response 88 (MyD88) [6, 7] . In lung epithelial cells, however, TLR3, which recognizes double-stranded RNA (dsRNA), is involved in sensing of influenza virus and induction of IFN and particularly proinflammatory responses [8, 9] . In contrast, the primary inducer of IFN in non-haematopoietic cells during influenza and other ssRNA virus infections is the cytosolic RNA sensor retinoic acid inducible gene 1 (RIG-I) [10] [11] [12] .
Following infection with influenza virus, RIG-I recognizes the panhandle structure of the incoming viral ribonucleoproteins (vRNPs) [13] . During subsequent viral transcription and replication further RNA species are produced, which are also detected by RIG-I [14] . Sensing of these RNA species induces RIG-I oligomerization and association with the mitochondrial anti-viral signalling protein (MAVS). This further activates the downstream kinases TANK-binding kinase 1 (TBK1) and IkappaB kinase epsilon (IKKE), and subsequently the transcription factors interferon regulatory factor (IRF)3, IRF7 and nuclear factor kappa B (NF-jB) [15] [16] [17] [18] [19] , leading ultimately to induction of type I IFN and proinflammatory cytokines. Production of type I IFN results in the induction of numerous IFNstimulated genes (ISGs), including interferon-inducible Mx protein (MX), ISG56 and IFN-induced transmembrane protein 3 (IFITM3), some of which have been proven to play a major role during influenza infection. For example, transgenic mice expressing the human MX1 gene exhibit enhanced influenza virus resistance [20] .
Several genome-wide association studies (GWAS) have aimed to address the influence of host genetics on the susceptibility and risk of severe disease during influenza virus infection [21] [22] [23] . However, overall, most studies have not been sufficiently large and have failed to identify factors of major importance. Finally, and perhaps surprisingly, neither B cell nor T cell deficiencies have been linked directly to an increased susceptibility to influenza. In 2015, a primary immunodeficiency involving the transcription factor IRF7 was found to cause increased susceptibility to severe influenza in a child who developed ARDS due to IAV infection. The IRF7 deficiency was demonstrated to result in decreased production of type I and III IFNs, causing increased viral replication in patient cells [24] . Further evidence of the importance of innate immune responses was provided by a recent publication reporting a role for the RIG-like receptor melanoma differentiation-associated protein 5 (MDA5) in protection against rhinovirus infection in childhood respiratory infections [25] .
Here we describe the identification of two heterozygous variants in DExD/H-box helicase 58 (DDX58) encoding the cytosolic RNA receptor RIG-I in a 41-year-old Caucasian male patient with severe influenza virus A infection, suggesting that functional defects in RIG-I increase susceptibility to severe influenza infection in humans.
Materials and methods

Patient material and cell lines
The patient described here, a 41-year-old Caucasian male with no previous notable medical history, was one among 12 patients identified based on review of the Extracorporeal Membrane Oxygenation (ECMO) database and medical files, including identification of IAV by polymerase chain reaction (PCR) from throat swabs and a clinical history of severe influenza at the intensive care unit (ICU) at Aarhus University Hospital. The patient provided informed written consent. Patient and volunteer healthy controls were included according to the Helsinki Declaration. All controls, as well as the patient, were non-smokers. Peripheral blood mononuclear cells (PBMCs) were purified by Ficoll density gradient centrifugation from heparinized blood and stored in liquid nitrogen until use. Fibroblasts were isolated from a skin biopsy. PBMCs and fibroblasts were cultured in RPMI-1640 with 10% heat-inactivated fetal bovine serum (HI-FBS) and 1% penicillin-streptomycin. RIG-I knock-out (KO) human embryonic kidney cells 293 (HEK293) cells were grown in Dulbecco's modified Eagle's medium (DMEM) with 10% FBS and 1% penicillin-streptomycin. HEK-blue IFN-a/b cells (Invivogen, Toulouse, France) were cultured in DMEM with 10% FBS, 1% penicillin-streptomycin, 100 lg/ml Normocin (Invivogen), 30 lg/ml blasticidin (Invivogen) and 100 lg/ml zeocin (Invivogen), and for experiments without blasticidin and zeocin. Monocyte-derived macrophages (MDMs) were differentiated from PBMCs in RPMI with 10% HI-FBS, 10% human AB serum, 1% penicillin-streptomycin and 15 ng/ml human macrophage colony stimulating factor (M-CSF) (Peprotech, London, UK). Medium was changed to DMEM with 10% human AB serum, 15 ng/ml M-CSF on days 4 and 7. On day 9 the MDMs were used for experiments.
Whole exome sequencing (WES)
WES was performed using Kapa HTP Library preparation and Nimblegen SeqCap EZ MedExome Plus kit and analysed with Nextseq version 2 chemistry [2 3 150 base pairs (bp)]. Single nucleotide polymorphisms (SNPs) were called relative to hg19.
Bioinformatics
The variant call files (VCF) were uploaded to Ingenuity variant analysis (IVA; Qiagen, Valencia, VA, USA). Variants were filtered based on rarity (frequency < 0Á1%), a gene list based on literature searches on Pubmed, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, Online Mendelian Inheritance in Man (OMIM), ClinVar and biological filters in IVA related to influenza infection, immunodeficiency and immune responses. Variants with combined annotation-dependent depletion (CADD) scores < mutation significance cut-off (MSC) scores were excluded [26, 27] . After identification of the p.P885S variant in DDX58, this gene was searched specifically for the presence of other variants, leading to identification of the more frequent p. were confirmed by manual inspection of BAM files using the UCSC genome browser. Variants in other genes with possible relevance for influenza infection but judged to be irrelevant in this patient due to low CADD score or high minor allele frequency (MAF) are listed in Supporting information, Table S1 
Ligands and viruses
Human influenza A virus strain A/PR/8/34 (H1N1) (Charles River, Burlington, MA, USA) was used for cell stimulations at multiplicity of infection (MOI) 5 0Á1, 1 or 2Á5 calculated from 50% egg infectious dose (EID50) titre. Human influenza A virus strain A/Hansa/Hamburg/05/09 (H1N1) was used for cell stimulations at MOI 5 0Á1 calculated from plaque-forming titres on Madin-Darby canine kidney (MDCK) cells. Sendai virus was used at 5 HAU/well. 5 0 pppdsRNA and poly(I:C) (Invivogen) were transfected into cells using lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA) using 1 lg/ml and 2 lg/ml, respectively.
Western blotting
Western blotting was performed as described previously [28] . Primary antibodies were: rabbit anti-RIG-I (AP1900A; Nordic Biosite, T€ aby, Sweden) 1 : 500; mouse anti-FLAG (F3165-1MG; Sigma Aldrich, St Louis, MO, USA) 1 : 10 000; rabbit anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (FL-335; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) 1 : 10 000; and horseradish peroxidase (HRP)-conjugated anti-beta actin antibody (ab49900; Abcam, Cambridge, UK) 1 : 25.000. Secondary antibodies were: donkey anti-rabbit (711-035-152, lot# 115414; Jackson ImmunoResearch, Newmarket, UK) and donkey anti-mouse (715-036-150, Jackson ImmunoResearch, Newmarket, UK) 1 : 10 000.
DNA isolation
Genomic DNA for WES was isolated from ethylenediamine teraacetic acid (EDTA)-stabilized blood using an EZ1 DNA Blood 350 ml Kit (Qiagen, Hilden, Germany). Genomic DNA from controls was isolated using the DNeasy Blood and Tissue Kit (Qiagen)
RNA isolation and reverse transcription-quantitative PCR (RT-qPCR)
PBMCs, MDMs and fibroblasts were stimulated or infected with the indicated ligands and viruses for 6 h. Cells were lysed and RNA was purified using the High Pure RNA Isolation Kit (Roche, Basel, Switzerland). cDNA was synthesized using the Quantitect Reverse Transcription Kit (Qiagen) and mRNA expression levels were measured by RT-qPCR using Fastmix II (Quanta Bio, Beverly, MA, USA) and TaqMan 
Type I IFN bioassay
PBMCs were infected with influenza A/PR/8/34 (H1N1) (Charles River) for 24 h and supernatants were collected. HEK blue IFNa/b cells were incubated with PBMC supernatants or IFN-a standards for 24 h. Secreted embryonic alkaline phosphatase (SEAP) protein levels were then measured in HEK blue cell culture supernatants using QuantiBlue (Invivogen).
Plasmids
R71H and P885S variants were introduced into pEF-BOS/ N-FLAG RIG-I WT vector by site-directed mutagenesis using Pfu Ultra II polymerase, with the following primers: R71H-sense:
Luciferase reporter assays RIG-I KO HEK293 T cells were kindly provided by Professor Veit Hornung, Munich [29] . Cells were seeded in 12-well plates and incubated for 24 h. Subsequently, the cells were transfected transiently with IFN-b promoter firefly luciferase reporter plasmid (970 ng/well), b-actin promoter renilla luciferase reporter plasmid (30 ng/well) and either 10 or 1000 ng/well RIG-I WT, R71H, P885S plasmids or plasmids harbouring both of the R71H and P885S variants, as indicated. All transfections were supplemented with pEF-BOS empty plasmid to a total of 1000 ng DNA/well. Transfections were performed using polyethylenimine (PEI). After 24 h incubation, cells were infected with 2Á5 MOI influenza A/PR/8/34 (H1N1) (Charles River) or 5 HAU SeV. Cells were lysed 18 h postinfection and firefly and renilla luciferase activity measured using Dual Glo (Promega, Madison, WI, USA), according to the manufacturer's instructions.
Statistics
Experiments were performed in experimental duplicates or triplicates, and most experiments were repeated two or three times. The Mann-Whitney rank sum test was used to determine statistical significance: non-significant (n.s.) P > 0Á05, * P 0Á05, ** P 0Á01 and *** P < 0Á001.
Ethics
The project was approved by the Regional Committee on Health Research Ethics (project no. 1-10-72-251-15) and the Danish Data Protection Agency (project no. 1-16-02-553-15). The patient provided informed written consent.
Results
Identification of two variants in DDX58 (RIG-I) in a patient with severe influenza
In this study, we enrolled 12 individuals who had been hospitalized previously at the ICU with severe influenza virus infection. WES was performed on all patients, allowing the identification of two variants in DDX58, the gene encoding RIG-I in one patient described here (Fig. 1a) . For the detailed medical story, see Supplementary information.
The first variant is a SNP (c.212G > A; rs72710678), which causes an amino acid substitution from an arginine to a histidine at position 71 in the RIG-I protein, p.R71H. This variant has a relatively high frequency in the general population of 1Á15% (gnomAD database). The other variant (c.2653C > T; rs138425677) causes an amino acid substitution of proline at position 885 to serine, p.P885S. This variant is extremely rare, with a frequency of 0.066% (gnomAD database). The CADD scores of R71H and P885S are 27Á2 and 32, respectively, and therefore above the MSC score for DDX58 of 26Á2, indicating that both variants are potentially deleterious for the protein function [26] .
Due to the long distance between the two RIG-I variants, it was impossible to determine the specific allelic identity of each variant by WES or conventional Sanger sequencing; moreover, samples from the parents of the patient were not available. Therefore, we cloned RIG-I mRNA from the patient into a vector and performed colony sequencing, revealing that the two variants were located at the same allele, thereby ruling out compound heterozygosity (data not shown). Both variants were confirmed to be heterozygous by Sanger sequencing (Fig. 1c) .
RIG-I is a large protein consisting of 925 amino acids. At the N-terminal part of the molecule, two consecutive caspase activation and recruitment domain are located [31] . They are followed by the helicase domain and, finally, the regulatory domain is found at the C-terminal part [31, 32] . The R71H variant is located in the first CARD domain, whereas the P885S variant is located in the regulatory domain, the latter of which is involved in 5 0 ppp-dsRNA binding [33] (Fig. 1d) . To examine the impact of the variants on mRNA expression of RIG-I, RT-qPCR was (Fig. 2b) . The crystal structure of RIG-I reveals that R71 makes multiple contacts with both other residues in RIG-I as well as with the ubiquitin chain, and binding of ubiquitin to activated RIG-I stabilizes the activated form of RIG-I and represents a crucial step. The substitution of arginine for histidine in the R71H variant is therefore likely to interfere with this interaction and subsequent signalling from RIG-I (Fig. 2c,d ). The P885S variant is located in the C-terminal domain of RIG-I responsible for binding the 5 0 ppp moiety of unmodified (uncapped) viral RNAs and the change from the sterically restricted proline to the much more flexible serine (Supporting information, Fig.  S1b ) may potentially affect the stability of the protein structure of this domain.
R71H and P885S variants each decrease RIG-I signalling activity
To investigate the impact of the identified variants on the ability of RIG-I to induce downstream signalling and IFN production, we expressed wild-type (WT) RIG-I, either of the two variants or RIG-I harbouring both amino acid substitutions together with two reporter plasmids carrying the IFN-b promoter coupled to firefly luciferase and a b-actin promoter coupled to renilla luciferase in HEK293T cells deficient for endogenous RIG-I expression. Infection with PR8 IAV in cells over-expressing RIG-I showed marked induction of IFN-b promoter activity for WT RIG-I, whereas the activity for the R71H RIG-I mutant was abolished completely and the P885S RIG-I mutant exhibited only minor activity. RIG-I with both variants also showed completely abolished activity (Fig. 3a) . In addition, infection with Sendai virus (SeV) induced high IFN-b promoter activity in cells expressing WT RIG-I, whereas significantly less activity was seen in both R71H and P885S RIG-Iexpressing cells as well as with RIG-I carrying both variants (Fig. 3b) . In line with these findings, over-expression of WT RIG-I (by transfection of 1000 ng plasmid) induced high IFN-b promoter activity on its own, whereas the response for the R71H variant and the combined R71H, P885S RIG-I was abolished almost completely (Fig. 3c) . The P885S variant, however, did not alter RIG-I signalling significantly without RNA stimulation (Fig. 3c) . Western blotting confirmed the absence of RIG-I in cells transfected with only empty vector. WT, R71H and the R71H, P885S double mutant were all expressed at similar levels, whereas the P885S variant showed slightly decreased expression (Fig. 3d) . Taken together, these data demonstrate that the RIG-I variants, particularly the R71H mutation, exert a major impact on the signalling activity causing severely decreased IFN-b inducing ability.
As both variants were heterozygous and located on the same allele, we investigated whether either of the variants might exhibit a dominant negative phenotype. To this end, WT RIG-I was expressed together with increasing amounts of R71H RIG-I (Fig. 3e) or P885S RIG-I (Fig. 3f) , together with the two reporter plasmids in HEK293T cells. However, in this cell system, neither of the two variants exerted any dominant negative effect upon the activity of WT RIG-I, thus demonstrating haploinsufficiency of the RIG-I defect in this patient.
Decreased responses to RIG-I ligands in patient cells
To examine further the functional consequences of the variants, we investigated the response to different RIG-I ligands in patient cells. PBMCs from the patient and healthy controls were stimulated with the RIG-I agonist 5 0 ppp-dsRNA, which has been found to be the optimal RIG-I ligand, and is also found in the panhandle structures of the vRNP of influenza [13, 34, 35] . Following 5 0 ppp- dsRNA transfection, IFN-b and CXCL10 mRNA responses were measured by RT-qPCR, revealing decreased responses in patient cells (Fig. 4a,b) . Next, MDMs were differentiated from patient and control PBMCs and stimulated with another RIG-I agonist poly(I:C). Whereas healthy control MDMs showed very variable responses, patient cells exhibited significantly lower responses than controls as measured by both IFN-b and CXCL10 (Fig. 4c,d ). Overall, these data are in line with the previous data, suggesting that the RIG-I variants decrease the ability of RIG-I to induce antiviral and proinflammatory responses to RNA ligands either present in the IAV genome or generated during viral replication in patient cells.
Normal IFN responses in the setting of significantly increased proinflammatory responses to influenza A virus in patients' cells
Patient and control PBMCs were infected with IAV PR8 strain or a clinical isolate from the 2009 pandemic (pdm H1N1), and induction of IFNs and CXCL10 was measured by RT-qPCR. Levels of IFN-b post-infection were similar in patient and control PBMCs (Fig. 5a,d ). In contrast, IFN-a2 and IFN-k1 were both expressed at higher levels in patient PBMCs compared to the two controls when infected with PR8 (Fig. 5b,c) , but tended to be largely equal to controls in response to pdm H1N1 (Fig.  5e,f) . In addition, production of biologically active type I IFN was examined in supernatants from patient and control PBMCs infected with IAV, revealing a slightly decreased production of active type I IFN, although this did not reach statistical significance (Fig. 5g) . For CXCL10, patient PBMCs showed similar levels compared controls when infecting with either PR8 IAV (Fig. 5h ) or pdm H1N1 (Fig. 5i) . Infection of patient and control MDMs with PR8 IAV confirmed the IFN-b results from the PBMCs, again showing similar expression levels (Fig. 5j) . RIG-I is believed to play a particularly important role in recognition of influenza virus in epithelial cells rather than in haematopoietic cells, and we therefore wanted to investigate the phenotype of cells closer related to the primary site of infection [36] . As we were unable to obtain pulmonary epithelial cells from the patient, instead we isolated patient fibroblasts derived from a skin biopsy. Fibroblasts from the patient and controls were transduced with eGFP-expressing lentivirus and infected subsequently with PR8 IAV at an . Statistics were calculated using the Mann-Whitney rank sum test. *P < 0Á05; ** P < 0Á01; ***P < 0Á001; n.s. 5 not significant. MOI of 0Á1, as this infectious dose was found to be optimal in fibroblasts. We found that patient PBMCs showed intermediate levels of IFNb and high levels of IFN-k1 mRNA, which were not significantly different than those measured in controls (Supporting information, Fig. S2a,b) . Of note, the lentiviral transduction did not alter responses to IAV, and in particular did not result in any significant IFN induction by the vector alone (Supporting information, Fig. S2e,f) .
RIG-I variants in severe influenza
As immunopathology constitutes an important aspect of influenza virus pathogenesis, we next examined the expression of two proinflammatory cytokines, TNF-a and IL-6, by RT-qPCR after IAV infection. Importantly, patient PBMCs demonstrated increased baseline levels of both cytokines compared to controls and further increased levels of TNF-a and IL-6 significantly following both PR8 IAV infection (Fig. 6a,b) and pdm H1N1 infection (Fig. 6c,d ). Proinflammatory responses were also analysed in patient MDMs which, similarly to patient PBMCs, displayed significantly increased baseline levels of IL-6 and highly increased IL-6 expression compared to controls upon IAV infection (Fig. 6e) . When measuring proinflammatory responses in fibroblasts, we found significantly elevated constitutive and inducible IL-6 levels in patient fibroblasts in response to PR8 IAV, but generally observed low levels of TNF-a and IL-6 in this cell type (Supporting information, Fig. S2c,d) .
In summary, these data demonstrate that patient PBMCs, MDMs and fibroblasts mount essentially normal interferon responses, but significantly increased proinflammatory responses upon IAV infection compared to controls in vitro.
Discussion
Here we present a study identifying two variants in the DDX58-encoded cytosolic RNA sensor RIG-I in an adult Caucasian male patient who developed severe influenza infection during the H1N1 swine flu pandemic in 2009-10.
The RIG-I R71H variant is located in the first CARD domain of RIG-I which, together with the second CARD domain, is responsible for oligomerization of RIG-I and interaction with the downstream adaptor MAVS [15] . Our results agree with a model according to which the R71H variant prevents a stable interaction with ubiquitin and thus destabilizes RIG-I oligomers. The other variant identified at . Statistics were calculated using the Mann-Whitney rank sum test. *P < 0Á05; n.s. 5 not significant. the P885 residue is located within the 5 0 ppp-RNA binding domain, and the rigidity of this domain is lost when proline is substituted with serine, possibly affecting the stability of the 5 0 ppp-RNA binding domain and hence lowering the affinity for 5 0 ppp-RNAs. This scenario would be predicted to cause impaired recognition of 5 0 ppp-RNAs and decreased signalling activity, as observed in the luciferase reporter assays. As the R71H variant was demonstrated to exert severely decreased signalling activity, both in the presence of dsRNA and independently of dsRNA, the mechanism by which this occurs may be through impaired RIG-I oligomerization and interaction with MAVS. Given that we did not observe any dominant negative effect of neither of the RIG-I variants upon WT RIG- I, we propose that the underlying mechanism involves haploinsufficiency in the patient.
Transfection of patient PBMCs and MDMs with the RIG-I ligands 5 0 ppp-dsRNA and poly(I:C), respectively, demonstrated decreased responses compared to healthy controls, indicating that the impaired signalling ability of RIG-I observed in the experimental HEK293T cell-based luciferase reporter assay also manifests in patient cells. Infection of patient PBMCs with IAV, however, did not demonstrate decreased IFN and CXCL10 responses. As haematopoietic cells mainly utilize other pattern recognition receptors (PRRs) than RIG-I during influenza infection [6, 7, 12] , the normal production of IFN-b and CXCL10 in patient PBMCs might reflect the existence of redundancy, i.e. the scenario that receptors such as TLR7 serve instead as the primary inducer of IFN responses to IAV in haematopoietic cells. In contrast, RIG-I is believed to play a central role in induction of IFN responses to IAV in fibroblasts and epithelial cells [10, 11] . However, fibroblasts isolated from patient skin showed intermediate expression levels of types I and III IFN after IAV infection. Although fibroblasts are probably more similar to lung epithelial cells than PBMCs with regard to expression and utilization of different PRRs, these cell types are not identical. A distinctive cellular phenotype might therefore be revealed by examination of patient lung epithelial cells, which unfortunately were not available to us in the present study.
A major finding of the present study was data showing that patient PBMCs exhibited significantly increased expression of the proinflammatory cytokines TNF-a and IL-6 upon infection with either of the two different IAV strains compared to controls, and with a similar pattern observed for patient fibroblasts and MDMs. Indeed, previous studies in mice have suggested a dysregulation of inflammatory pathways during influenza infection in RIG-I-deficient cells, as genes involved in apoptosis, TLR and IL-1 signalling and induction of proinflammatory responses were found to be up-regulated during influenza infection [11] . Additionally, a recent study provided evidence of up-regulated expression of the proinflammatory cytokines IL-6, IL-8 and TNF-a by IAV infection in RIG-Ideficient lung epithelial cells [25] . Based on these data, we speculate that RIG-I deficiency may result in elevated proinflammatory responses causing exaggerated immunopathology in the lungs, possibly secondary to increased IAV replication. This scenario would be predicted to translate into a more severe course of disease consistent with the well-recognized role of immunopathology in severe influenza [37] . In line with this idea, TLR3 induces mainly proinflammatory responses during influenza infection of lung epithelial cells [9] , and indeed TLR3-deficient mice have decreased inflammation and mortality compared to WT mice [38] . Therefore, impaired RIG-I responses might lead to increased proinflammatory responses, mediated possibly through TLR3 and TLR7 recognition of viral dsRNA or ssRNA, respectively, leading to enhanced immunopathology and lung injury during influenza infection.
As we did not observe a significant phenotype in patient cells with respect to decreased anti-viral IFN responses to IAV, it is not possible to conclude with certainty that the identified RIG-I variants are direct causes of the severe disease course experienced by the patient. However, based on the finding of considerable signaling deficiency exhibited by the RIG-I variants with regard to induction of IFN-b, combined with the findings of consistently significantly increased proinflammatory cytokine responses in patient PBMCs, macrophages and fibroblasts compared to controls, we suggest that the discovered variants exert an important role upon viral recognition and generation of appropriate anti-viral and proinflammatory responses. Moreover, these data underscore the importance of studying further the essential role of inflammatory responses causing pathology during influenza.
Our finding that IFN production from PBMCs and MDMs in response to IAV from patients was largely similar to that from control PBMCs, despite data demonstrating impaired IFN induction in HEK293 cells expressing these RIG-I mutants, may seem surprising. One explanation for this apparent paradox may be the existence of redundancy in pathogen recognition of IAV as a major determinant for whether the RIG-I defect translates into a cellular phenotype with respect to IFN production in a given cell type. In epithelial cells, in which RIG-I plays an essential and dominant role in IAV recognition, a mutation in the RIG-I encoding gene DDX58 impairing the signalling capacity of RIG-I is more likely to result in reduced IFN responses in vitro. Indeed, epithelial cells are the prime targets for infection by IAV in the respiratory tract, and if these cell types do not mount sufficient anti-viral IFN responses early during infection, this may result in subsequent increased viral load, exaggerated inflammatory responses, immunopathology and a severe disease course.
In conclusion, we therefore advocate that the presence of the R71H and P885S variants should be investigated in future studies on genetic susceptibility to severe disseminated infection with IAV and other ssRNA viruses, to which RIG-I signalling is believed to play a major role. This approach will contribute to clarifying further the role of defects in RIG-I and other RNA-recognizing PRRs in increased susceptibility to severe viral infection in humans. 
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